Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Jul 2, 2013

30339_dirs_2013-07-02_4bba383f-f4a8-4ea1-8d31-313fa8582c79.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-06-28

Reporting Person: Michels Douglas A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-06-28 Phantom Stock Unit $ A 248.5100 Acquired Common Stock (248.5100) Direct

Footnotes

F1: Awards of phantom stock units are to be settled only in cash upon the reporting person's termination as a director.

F2: Reflects additional Phantom Stock Units credited through dividend reinvestment based on most recent plan statement.